Peptide for use in chronic complications of diabetes
Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Description
|
Description |
SOCS1-derived peptide for prevention and treatment of chronic complications of diabetes, especially complications affecting the kidneys, nervous and vascular systems. |
|
Applications |
Diabetic nephropathy, age-related macular degeneration, glaucoma and pigmentary retinitis, diabetic nephropathy, diabetic angiopathy, diabetic microangiopathy, diabetic macroangiopathy, diabetic atherosclerosis, diabetic foot, and peripheral arterial disease. |
|
Protection status |
Co-ownership of the invention. Request for national patent submitted to the Spanish Patent and Trademark Office. International application requested via co-ownership of the patent. |
|
Cooperation requested |
Search for licensees for the patent Search for partners to undertake joint development of the technology |
|
Therapy area |
Ophthalmology Nephrology Cardiology |
- Status:
- N/A
- Health technology:
- N/A